Drug Profile
AHC 93
Latest Information Update: 19 Nov 2003
Price :
$50
*
At a glance
- Originator Toho University
- Class Anti-ischaemics; Cardiotonics
- Mechanism of Action Glycoprotein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Reperfusion injury
Most Recent Events
- 19 Nov 2003 Discontinued - Preclinical for Reperfusion injury in Japan (unspecified route)
- 11 Oct 1999 Preclinical development for Reperfusion injury in Japan (Unknown route)